Bacterial gastroenteritis is infection in the gut (gastrointestinal tract). Major bacteria causing gastroenteritis are C. difficile, C. jejuni, shigella, E. coli, and several species of salmonella. These bacteria are usually transmitted by means of ingesting contaminated food or liquids, person-to-person contact, and contact with animals. The diseases caused by these bacteria may be asymptomatic or may have mild to severe symptoms. Some of the common symptoms caused by enteric bacteria include diarrhea, nausea and vomiting, abdominal cramps, and weight loss. Earlier, cultural tests were the primary method of bacterial gastroenteritis diagnosis. They required a complex medium to grow the bacterium. Nowadays, advanced tests such as PCR and commercial ELISA tests have been developed for direct detection of pathogen from stool specimen. Clostridium infection is the major contributor to bacterial gastroenteritis. Clostridium difficile or C.difficile is a genus of bacteria that is one of the leading causes of hospital acquired colitis in patients who take antibiotics and other drugs that alter their normal intestinal flora. The diagnosis is usually made by identifying C.difficile toxins or toxigenic C.difficile. Toxigenic C.difficile is detected by growing C.difficile from the stool specimen of the patient in a culture medium..
Increasing awareness about new enteric disease testing technologies, adoption of enteric disease diagnostic products in hospitals and diagnostic laboratories, and increase in prevalence of various infectious diseases among elderly people are expected to drive the bacterial gastroenteritis testing market during the forecast period. In addition, increasing demand in emerging countries such as India and China is likely to boost the bacterial gastroenteritis testing market. Water and foodborne diseases are on the rise globally, especially in underdeveloped and developing nations. Bacterial gastroenteritis has been identified as one of the major causative organisms of water and foodborne diseases. Prevalence of diarrhea and hemolytic uremic syndrome (HUS) is increasing rapidly across the world. These are mostly caused by bacterial gastroenteritis infections. Moreover, the epidemic of E. coli infections in Germany during 2011 had spread to various parts of the world (more than 10 countries), including the U.S., the U.K., Spain, and France.Furthermore, countries in the WHO European region have reported significant number of infections caused due to verocytotoxin-producing E. coli O104:H4 strains.
The bacterial gastroenteritis testing market can be segmented based on disease indication, testing method, end-user, and geography. Based on disease indication, the bacterial gastroenteritis testing market can be categorized into C.difficile infection, campylobacteriosis, cholera, E.coli infection, H.pylori infection, salmonellosis, and shigellosis. In terms of testing method, the bacterial gastroenteritis testing market can be classified into immunoassay testing, conventional testing, and molecular diagnostic testing. In terms of end-user, the enteric disease testing market can be divided into hospitals, diagnostic laboratories, and physician offices.
In terms of geography, the bacterial gastroenteritis testing market can be classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the global market for bacterial gastroenteritis testing products due to high awareness among people along with rapidly increasing demand for technologically advanced diagnostic testing products. The U.S. is a major contributor to the bacterial gastroenteritis testing market, with a high adoption rate of technologically advanced molecular diagnostic systems. North America accounts for a significant market share of the global bacterial gastroenteritis testing market, followed by Europe. Demand for bacterial gastroenteritis testing products is high in developed countries in Europe such as the U.K., Germany, and France. In Asia Pacific, increasing demand for bacterial gastroenteritis testing products from countries such as India, China, and Japan is expected to boost the bacterial gastroenteritis testing market. However, affordability and lack of availability of innovative bacterial gastroenteritis testing products have become a restraining factor for the bacterial gastroenteritis testing market in developing and undeveloped regions such as the Middle East & Africa and Latin America. The market in these regions is expected to expand at a slow pace, with contributions from some developing countries such as Brazil and South Africa. Latin American countries such as Mexico and Brazil are expected to offer considerable potential for driving the bacterial gastroenteritis testing market due to evolving medical structure and increasing awareness about diagnostic testing. The major players operating in this market include Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, Coris BioConcept, DiaSorin, Meridian Bioscience, Inc., Pro-Lab Diagnostics, Inc., and TECHLAB, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.